NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,201,991 | +1.4% | 51,070 | +0.5% | 0.26% | +6.1% |
| Q2 2023 | $5,128,247 | +9.7% | 50,820 | 0.0% | 0.25% | +2.1% |
| Q1 2023 | $4,675,440 | -4.7% | 50,820 | -6.0% | 0.24% | -10.4% |
| Q4 2022 | $4,905,230 | +34.2% | 54,070 | +12.5% | 0.27% | +23.3% |
| Q3 2022 | $3,654,000 | +2.6% | 48,070 | +14.1% | 0.22% | +5.3% |
| Q2 2022 | $3,563,000 | +11.9% | 42,145 | +16.1% | 0.21% | +33.3% |
| Q1 2022 | $3,184,000 | +22.8% | 36,285 | +22.4% | 0.16% | +30.0% |
| Q4 2021 | $2,593,000 | +9.8% | 29,645 | +2.6% | 0.12% | +0.8% |
| Q3 2021 | $2,362,000 | -9.3% | 28,881 | +1.2% | 0.12% | -10.5% |
| Q2 2021 | $2,605,000 | +6.8% | 28,550 | 0.0% | 0.13% | +0.8% |
| Q1 2021 | $2,440,000 | -9.5% | 28,550 | 0.0% | 0.13% | -13.7% |
| Q4 2020 | $2,696,000 | +8.6% | 28,550 | 0.0% | 0.15% | -3.8% |
| Q3 2020 | $2,483,000 | +8.4% | 28,550 | +8.9% | 0.16% | -1.2% |
| Q2 2020 | $2,290,000 | +15.0% | 26,225 | +8.6% | 0.16% | -4.7% |
| Q1 2020 | $1,991,000 | -14.0% | 24,150 | -1.2% | 0.17% | +9.0% |
| Q4 2019 | $2,314,000 | +8.9% | 24,439 | 0.0% | 0.16% | +1.3% |
| Q3 2019 | $2,124,000 | -3.7% | 24,439 | +1.2% | 0.15% | -7.3% |
| Q2 2019 | $2,205,000 | -5.0% | 24,150 | 0.0% | 0.16% | -9.3% |
| Q1 2019 | $2,322,000 | +12.1% | 24,150 | 0.0% | 0.18% | -4.2% |
| Q4 2018 | $2,072,000 | -0.4% | 24,150 | 0.0% | 0.19% | +15.9% |
| Q3 2018 | $2,081,000 | +30.2% | 24,150 | +14.2% | 0.16% | +19.7% |
| Q2 2018 | $1,598,000 | -6.5% | 21,150 | 0.0% | 0.14% | -8.7% |
| Q1 2018 | $1,710,000 | -3.7% | 21,150 | 0.0% | 0.15% | -3.2% |
| Q4 2017 | $1,776,000 | -2.2% | 21,150 | 0.0% | 0.16% | -6.1% |
| Q3 2017 | $1,816,000 | +2.3% | 21,150 | -0.6% | 0.16% | -2.9% |
| Q2 2017 | $1,776,000 | +24.7% | 21,275 | +11.0% | 0.17% | +18.9% |
| Q1 2017 | $1,424,000 | -2.5% | 19,175 | -4.4% | 0.14% | -7.7% |
| Q4 2016 | $1,460,000 | -16.1% | 20,050 | -9.1% | 0.16% | -19.7% |
| Q3 2016 | $1,741,000 | -4.3% | 22,050 | 0.0% | 0.19% | -4.0% |
| Q2 2016 | $1,819,000 | +7.3% | 22,050 | -5.8% | 0.20% | +2.0% |
| Q1 2016 | $1,695,000 | -26.7% | 23,400 | -12.9% | 0.20% | -31.8% |
| Q4 2015 | $2,311,000 | -7.0% | 26,860 | +0.2% | 0.29% | -11.9% |
| Q3 2015 | $2,485,000 | -2.4% | 26,800 | +3.5% | 0.33% | +0.3% |
| Q2 2015 | $2,547,000 | +10.8% | 25,900 | +11.2% | 0.33% | +10.5% |
| Q1 2015 | $2,298,000 | +16.4% | 23,300 | +9.4% | 0.30% | +13.8% |
| Q4 2014 | $1,974,000 | -1.1% | 21,300 | +0.5% | 0.26% | -11.3% |
| Q3 2014 | $1,996,000 | -0.7% | 21,200 | -4.5% | 0.29% | -1.0% |
| Q2 2014 | $2,011,000 | +2.2% | 22,210 | -4.0% | 0.30% | +8.0% |
| Q1 2014 | $1,967,000 | +5.8% | 23,135 | 0.0% | 0.27% | +5.0% |
| Q4 2013 | $1,860,000 | +4.8% | 23,135 | 0.0% | 0.26% | -8.1% |
| Q3 2013 | $1,775,000 | +8.5% | 23,135 | 0.0% | 0.28% | +0.7% |
| Q2 2013 | $1,636,000 | – | 23,135 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |